Florence Laigle
Paris, 75013, France
NCT Number: NCT02892708
The objective of this study is to evaluate the efficacy and safety of surgical resection in elderly patients 70 years or older with a supratentorial glioblastoma de novo. The sensitivity of Magnetic Resonance Spectroscopy with perfusion sequences in the diagnosis of malignant glioma in the elderly will also be studied.
Looking for future studies?
Notify Me70 year and older
All sexes
Interventional
Phase 3
Paris, 75013, France
Currently, the standard treatment for gliomas is based on surgical resection followed by radiation therapy.
However in patients 70 and older, surgery is not systematic, before radiotherapy. Moreover, at these ages, surgery is likely to be less well tolerated in general terms.
The aim of this study is to try to determine the best treatment between radiation therapy associated with the surgical treatment and care by radiotherapy alone, after a brain biopsy. This is a randomized, two arms, multicenter, open study.
In the two weeks following the radiological diagnosis of a lesion highly suggestive of a high-grade glioma, patients will be randomized to either arm surgery (partial or complete excision) + radiotherapy or in the radiotherapy alone arm. Within 5 weeks after surgery (biopsy or excision), all patients will receive treatment with focal radiotherapy.
A central review blades and MRI data will be organized after the inclusion of patients.
A maximum of 135 patients will participate in this trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
partial or complete resection followed by radiotherapy
radiotherapy after a brain biopsy
Time frame: From date of randomization until the date of death from any cause, assessed up to 100 months
Assistance Publique - Hôpitaux de Paris
Other
Acronym: CSA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02303678
Brain Diseases, Brain Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT03213678
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma
Birmingham, Alabama, United States
View Trial DetailsNCT04817254
Astrocytoma, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03746080
Astrocytoma, Glioblastoma
Palo Alto, California, United States
View Trial Details